To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CRTC3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
238 supporting clones for gene CRTC3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK090443 Spleen .a 1 to 5195 1 to 5194 S121N Q131K A132L D133I N134M ... tiling clone, available from FLJ,   5194/5194
(100 %)
10 diff
(99.9 %id)
DB504327 hypothalamus .a 2 to 122 1 to 121       121/121
(100 %)
0 diff
(100 %id)
AL556332 placenta .a 3 to 846 1 to 843       843/843
(100 %)
5 diff
(99.5 %id)
BQ945777 leiomyosarcoma, uterus .a 13 to 846 1 to 841   tiling clone,   839/943
(88 %)
14 diff
(98.6 %id)
NM_001042574.1   .a 42 to 5209 1 to 5168   RefSeq,   5168/5168
(100 %)
0 diff
(100 %id)
CR974669 T-Lymphocytes .a 94 to 607 1 to 514       514/516
(99 %)
1 diff
(99.9 %id)
EB387374 eye, optic nerve .a 298 to 1116 1 to 820       820/820
(100 %)
2 diff
(99.8 %id)
BF997680 placenta_normal .a 331 to 766 435 to 6       428/435
(98 %)
13 diff
(97.1 %id)
AK074170 Spleen .a 499 to 5195 9 to 4705   tiling clone, available from FLJ,   4697/4705
(99 %)
8 diff
(99.9 %id)
DA853638 placenta .a 622 to 1189 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CD631578   .a 672 to 1024 11 to 363       353/363
(97 %)
9 diff
(97.6 %id)
CD631579   .a 672 to 1020 348 to 1       348/360
(96 %)
2 diff
(99.5 %id)
BG946433 bladder_tumor .a 690 to 899 214 to 7       210/214
(98 %)
9 diff
(95.8 %id)
BF850946 lung_normal .a 714 to 1244 538 to 10     Submitted on the opposite strand 529/538
(98 %)
9 diff
(98.4 %id)
BX369611   .a 759 to 1412 1 to 653       653/653
(100 %)
22 diff
(96.7 %id)
BX369610   .a 775 to 1589 1 to 811       811/836
(97 %)
26 diff
(96.9 %id)
BX493097   .a 779 to 1320 1 to 542       542/542
(100 %)
0 diff
(100 %id)
EH336127   .a 780 to 846 1 to 67       67/68
(98 %)
2 diff
(97.1 %id)
BP238198 Liver .a 794 to 1401 1 to 608       608/608
(100 %)
3 diff
(99.6 %id)
AK025521   .a 795 to 5208 1 to 4414   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 4414/4414
(100 %)
3 diff
(100.0 %id)
AK225300 Liver .a 795 to 2662 1 to 1868       1868/1868
(100 %)
1 diff
(100.0 %id)
U77576   .a 916 to 1056 157 to 17       141/164
(85 %)
0 diff
(100 %id)
DB280469 uterus .a 921 to 1464 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DB288138 uterus .a 957 to 1505 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BF933094 nervous_tumor .a 963 to 1271 1 to 309       309/390
(79 %)
3 diff
(99.3 %id)
DA017081 adrenal gland .a 1016 to 1582 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BC074730 Brain, PCR rescued clones .a 1019 to 2048 1 to 1030   available from MGC,   1030/1030
(100 %)
1 diff
(100.0 %id)
BF884801 lung_tumor .a 1045 to 1392 368 to 22     Submitted on the opposite strand 347/368
(94 %)
3 diff
(99.2 %id)
DB216845 trachea .a 1089 to 1649 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
BE903412 choriocarcinoma, placenta .a 1173 to 1781 48 to 688       599/991
(60 %)
45 diff
(95.5 %id)
DB217225 trachea .a 1183 to 1752 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB278995 uterus .a 1204 to 1748 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BP365179 lung .a 1217 to 1798 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB229859 trachea .a 1219 to 1778 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB163675 thymus .a 1271 to 1843 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA219643 brain .a 1324 to 1801 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA212355 brain .a 1335 to 1929 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
BU187287 epithelioid carcinoma, Pancreas .a 1475 to 2223 12 to 767       756/871
(86 %)
25 diff
(97.2 %id)
AA724459 pooled .a 1601 to 2069 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
BP230904 brain .a 1624 to 2207 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CF137590 lymph .a 1639 to 2199 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
TI_154167053   .a 1645 to 2438 89 to 886       798/798
(100 %)
18 diff
(97.8 %id)
DB220706 trachea .a 1668 to 2240 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB232066 trachea .a 1684 to 2272 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
CF121950 lymph .a 1764 to 2340 1 to 576       576/576
(100 %)
5 diff
(99.2 %id)
TI_154181328   .a 1771 to 2636 76 to 937       862/864
(99 %)
32 diff
(96.3 %id)
DA945385 Spleen .a 1876 to 2433 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA437701 tongue, tumor tissue .a 1934 to 2479 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BG328132 adenocarcinoma cell line, colon .a 1945 to 2736 1 to 788       788/923
(85 %)
30 diff
(96.8 %id)
BG385622 adenocarcinoma cell line, colon .a 1945 to 2776 1 to 825       825/826
(99 %)
32 diff
(96.2 %id)
DB076244 testis .a 1951 to 2499 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
BE901698 choriocarcinoma, placenta .a 2034 to 2814 776 to 1     Submitted on the opposite strand 776/817
(94 %)
9 diff
(98.9 %id)
DB163138 thymus .a 2039 to 2631 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
BE902295 choriocarcinoma, placenta .a 2050 to 2813 757 to 2     Submitted on the opposite strand 756/975
(77 %)
0 diff
(100 %id)
DA854349 placenta .a 2051 to 2632 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CN298838 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2074 to 2276 1 to 202       202/202
(100 %)
1 diff
(99.6 %id)
BE731997 choriocarcinoma, placenta .a 2076 to 2814 736 to 2     Submitted on the opposite strand 735/740
(99 %)
0 diff
(100 %id)
DA636792 Kidney .a 2093 to 2666 2 to 575   capped   574/574
(100 %)
7 diff
(98.8 %id)
DA410224 thalamus .a 2100 to 2645 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
BE280546 choriocarcinoma, placenta .a 2113 to 2813 699 to 1     Submitted on the opposite strand 699/745
(93 %)
5 diff
(99.4 %id)
AW852033 colon .a 2117 to 2698 582 to 1       582/582
(100 %)
3 diff
(99.5 %id)
BG479073 choriocarcinoma, placenta .a 2132 to 2825 702 to 10     Submitted on the opposite strand 693/703
(98 %)
0 diff
(100 %id)
BG479751 choriocarcinoma, placenta .a 2151 to 2825 686 to 10     Submitted on the opposite strand 677/689
(98 %)
0 diff
(100 %id)
BE901376 choriocarcinoma, placenta .a 2170 to 2813 647 to 1     Submitted on the opposite strand 647/914
(70 %)
21 diff
(97.8 %id)
BE279148 choriocarcinoma, placenta .a 2178 to 2814 644 to 1     Submitted on the opposite strand 644/645
(99 %)
21 diff
(96.8 %id)
DB099734 testis .a 2189 to 2745 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BE281187 choriocarcinoma, placenta .a 2225 to 2812 660 to 58     Submitted on the opposite strand 603/660
(91 %)
0 diff
(100 %id)
DB261388 uterus .a 2227 to 2731 2 to 514   capped   513/520
(98 %)
15 diff
(97.2 %id)
DA115381 cerebellum .a 2284 to 2805 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
BE280233 choriocarcinoma, placenta .a 2294 to 2812 521 to 3     Submitted on the opposite strand 519/521
(99 %)
0 diff
(100 %id)
AW811735 stomach .a 2300 to 2796 500 to 1       500/500
(100 %)
13 diff
(97.4 %id)
DA055222 cerebellum .a 2302 to 2844 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA150207 amygdala .a 2302 to 2871 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DB147458 thymus .a 2303 to 2862 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BU507559 leiomyosarcoma, uterus .a 2324 to 3169 1 to 852       852/852
(100 %)
8 diff
(99.1 %id)
DA555847   .a 2326 to 2886 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB086124 testis .a 2329 to 2883 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CR993243 T-Lymphocytes .a 2419 to 3059 1 to 641       641/649
(98 %)
1 diff
(99.9 %id)
DA584406 lung .a 2420 to 2955 2 to 537   capped   536/539
(99 %)
1 diff
(99.9 %id)
BF892345 marrow .a 2481 to 2840 1 to 360       360/367
(98 %)
6 diff
(98.4 %id)
AL602479 human skeletal muscle .a 2501 to 3006 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
BQ344172 nervous_tumor .a 2528 to 2625 1 to 96       96/115
(83 %)
5 diff
(95.7 %id)
DA965165 stomach .a 2541 to 3105 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA298845 hippocampus .a 2554 to 3131 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA352533 substantia nigra .a 2561 to 3130 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BQ689215 ductal carcinoma, cell line, Pancreas .a 2607 to 3285 1 to 679       679/852
(79 %)
6 diff
(99.3 %id)
BQ068919 brain, neuroblastoma, cell line .a 2643 to 3582 1 to 948       948/953
(99 %)
18 diff
(98.2 %id)
DA937349 Spleen .a 2662 to 3232 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BI524113 pooled lung and spleen .a 2698 to 3413 1 to 713       713/714
(99 %)
8 diff
(98.9 %id)
TI_44158719   .a 2700 to 3413 53 to 763       711/764
(93 %)
7 diff
(99.1 %id)
DA343789 substantia nigra .a 2709 to 3275 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
AL360259   .a 2710 to 5195 1 to 2486   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2486/2487
(99 %)
1 diff
(100.0 %id)
DA783500 brain .a 2715 to 3278 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
CD557412 testis .a 2790 to 3550 1 to 773       773/940
(82 %)
22 diff
(97.7 %id)
DB127190 thymus .a 2824 to 3384 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP383297 ilea mucosa .a 2842 to 3384 1 to 544       544/544
(100 %)
7 diff
(98.8 %id)
BP383357 ilea mucosa .a 2845 to 3438 1 to 601       601/606
(99 %)
21 diff
(96.6 %id)
CR992907 T-Lymphocytes .a 2865 to 3604 1 to 741       741/744
(99 %)
2 diff
(99.8 %id)
BG999637 head_normal .a 2920 to 3393 500 to 24       477/505
(94 %)
0 diff
(100 %id)
DA288769 hippocampus .a 2986 to 3547 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB245433 uterus, tumor tissue .a 3076 to 3639 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA588008 lung .a 3166 to 3752 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DA069748 cerebellum .a 3167 to 3718 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BM698139 eye, fetal eyes .a 3196 to 3586 1 to 391     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
BM784357 stomach .a 3199 to 3527 1 to 329       329/329
(100 %)
0 diff
(100 %id)
DA344806 substantia nigra .a 3203 to 3762 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
BP195861 brain .a 3207 to 3791 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DA479540   .a 3207 to 3769 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BQ649736 hepatocellular carcinoma, cell line, Liver .a 3395 to 4252 24 to 886       863/996
(86 %)
20 diff
(98.0 %id)
BP298078   .a 3443 to 4012 1 to 571       571/573
(99 %)
3 diff
(99.5 %id)
BM764667 Ascites, stomach .a 3459 to 4095 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BI524703 pooled lung and spleen .a 4369 to 5149 798 to 1       798/798
(100 %)
40 diff
(95.0 %id)
TI_44158720   .a 4369 to 5149 798 to 1       798/798
(100 %)
40 diff
(95.0 %id)
BM667305 eye, fetal eyes .a 4764 to 5208 463 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 445/445
(100 %)
0 diff
(100 %id)
NM_022769.3   .b 1 to 5171 1 to 5171 exact RefSeq,   5171/5171
(100 %)
0 diff
(100 %id)
AY360173   .b 100 to 2317 1 to 2219   tiling clone,   2219/2221
(99 %)
13 diff
(99.5 %id)
BC074731 Brain, PCR rescued clones .b 978 to 2010 1 to 1033   tiling clone, available from MGC,   1033/1033
(100 %)
0 diff
(100 %id)
CV811132 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1298 to 1983 1 to 685       685/685
(100 %)
3 diff
(99.6 %id)
DA112853 cerebellum .b 1351 to 1903 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
AW083802 colon, moderately differentiated adenocarcinoma .b 1386 to 1947 1 to 563     Submitted on the opposite strand 563/564
(99 %)
11 diff
(98.1 %id)
AW118593 pooled .b 1460 to 2031 570 to 2       569/576
(98 %)
2 diff
(99.7 %id)
BP289518 lung .b 1586 to 2166 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CN298837 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1606 to 2330 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
DB230662 trachea .b 1698 to 2257 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BQ943790 large cell carcinoma, lung .b 1702 to 2548 1 to 855   tiling clone,   855/965
(88 %)
27 diff
(97.3 %id)
BQ941303 large cell carcinoma, lung .b 1702 to 2590 1 to 889   tiling clone,   889/889
(100 %)
3 diff
(99.7 %id)
DA800346 brain .b 1703 to 2221 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
CB046168 2 pooled tumors (clear cell type), Kidney .b 1728 to 2424 9 to 705     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 697/705
(98 %)
6 diff
(99.2 %id)
DA122677 cerebellum .b 1740 to 2276 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
CB046167 2 pooled tumors (clear cell type), Kidney .b 4519 to 5157 668 to 30   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 639/639
(100 %)
2 diff
(99.7 %id)
BF593236 Kidney .c 1 to 630 630 to 1 L3S D9N tiling clone,   630/631
(99 %)
5 diff
(99.3 %id)
CB992454 placenta, pre-eclamptic placenta .d 1 to 705 28 to 734 exact tiling clone,   707/830
(85 %)
15 diff
(98.2 %id)
BX283365 epithelioid carcinoma cell line, Pancreas .e 1 to 413 1 to 413 exact tiling clone,   413/413
(100 %)
1 diff
(99.8 %id)
BI194099 epithelioid carcinoma cell line, Pancreas .e 1 to 577 1 to 580 R8G R9G P10L V11W D12T ... available from MGC,   580/962
(60 %)
16 diff
(98.4 %id)
BC019060 Pancreas, epithelioid carcinoma .e 2 to 1421 1 to 1420   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1420/1420
(100 %)
1 diff
(100.0 %id)
DA329876 hippocampus .f 1 to 566 2 to 568 exact tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
CN271696 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1 to 579 1 to 582 S75N tiling clone,   582/582
(100 %)
5 diff
(99.2 %id)
AK024981 colon .h 1 to 2446 1 to 2447 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2447/2447
(100 %)
6 diff
(99.8 %id)
BE908028 epithelioid carcinoma, Pancreas .h 519 to 1162 648 to 1   tiling clone, Submitted on the opposite strand 648/830
(78 %)
5 diff
(99.4 %id)
BI094160 cervix .h 558 to 1216 1 to 658       658/686
(95 %)
12 diff
(98.3 %id)
BM986954 mixed .h 648 to 932 13 to 297     Submitted on the opposite strand 285/297
(95 %)
6 diff
(98.0 %id)
AA897770 pooled .h 700 to 878 179 to 1       179/179
(100 %)
0 diff
(100 %id)
AW768609 lymph node, lymphoma, follicular mixed small and largecell .h 815 to 1220 406 to 1       406/406
(100 %)
10 diff
(97.6 %id)
BG572368 placenta .h 1088 to 1840 1 to 749   tiling clone,   749/758
(98 %)
13 diff
(98.3 %id)
D78663 placenta .h 1448 to 1799 1 to 353       353/353
(100 %)
2 diff
(99.5 %id)
DB575569 hypothalamus .h 1762 to 2446 1 to 685     Submitted on the opposite strand 685/685
(100 %)
8 diff
(98.9 %id)
DB577408 hypothalamus .h 1956 to 2446 1 to 491     Submitted on the opposite strand 491/491
(100 %)
1 diff
(99.8 %id)
DB294238   .i-u 1 to 759 2 to 760   tiling clone, capped   759/759
(100 %)
5 diff
(99.4 %id)
BE537665 cervix .i-u 28 to 546 1 to 546       546/546
(100 %)
28 diff
(94.9 %id)
BX350380   .i-u 33 to 931 888 to 1       888/888
(100 %)
14 diff
(98.5 %id)
BM848265 myeloma .i-u 43 to 512 1 to 470   tiling clone,   470/470
(100 %)
0 diff
(100 %id)
BU168168 large cell carcinoma, lung .i-u 118 to 959 1 to 856       856/910
(94 %)
14 diff
(98.5 %id)
AW748771 breast .i-u 125 to 426 306 to 2       305/306
(99 %)
0 diff
(100 %id)
BU528448 epidermoid carcinoma, cell line, lung .i-u 135 to 1047 1 to 923       923/923
(100 %)
17 diff
(98.2 %id)
BE904128 epithelioid carcinoma, Pancreas .i-u 143 to 935 1 to 778       778/1087
(71 %)
21 diff
(98.1 %id)
BE151078 head_neck .i-u 151 to 266 1 to 117       117/117
(100 %)
6 diff
(94.9 %id)
CN295792 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i-u 158 to 654 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
W60673 heart .i-u 159 to 779 1 to 608       608/613
(99 %)
19 diff
(97.0 %id)
FN139109 breast carcinoma .i-u 281 to 391 109 to 1     Submitted on the opposite strand 109/109
(100 %)
2 diff
(98.2 %id)
AW748913 breast .i-u 420 to 571 1 to 151       151/188
(80 %)
12 diff
(93.7 %id)
W73556 heart .i-u 423 to 847 1 to 425   fully sequenced,   425/425
(100 %)
4 diff
(99.1 %id)
CN481261 eye .i-u 424 to 1039 10 to 625   tiling clone,   616/625
(98 %)
6 diff
(99.1 %id)
BE548981 cervical carcinoma cell line, cervix .i-u 448 to 1139 1 to 675       675/878
(76 %)
32 diff
(96.4 %id)
EH349057   .i-u 493 to 570 1 to 78       78/85
(91 %)
4 diff
(95.3 %id)
R16266 whole brain .i-u 536 to 910 1 to 376       376/376
(100 %)
8 diff
(97.9 %id)
AA931690 carcinoid, lung .i-u 536 to 800 289 to 30       260/289
(89 %)
10 diff
(96.6 %id)
CA391684 eye, RPE/choroid .i-u 546 to 1177 1 to 632       632/632
(100 %)
0 diff
(100 %id)
BE788249 large cell carcinoma, lung .i-u 584 to 1041 1 to 457       457/457
(100 %)
2 diff
(99.6 %id)
BX280445 cervical carcinoma cell line, cervix .i-u 651 to 1117 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BI256439 cervical carcinoma cell line, cervix .i-u 651 to 1593 11 to 944       934/971
(96 %)
21 diff
(97.9 %id)
BI090754 cervix .i-u 672 to 1519 1 to 859       859/932
(92 %)
62 diff
(93.4 %id)
BF061517 pooled .i-u 681 to 1221 541 to 1       541/541
(100 %)
0 diff
(100 %id)
BF114667 pooled .i-u 752 to 1222 471 to 1       471/471
(100 %)
3 diff
(99.4 %id)
AA640883   .i-u 756 to 1190 1 to 435       435/435
(100 %)
6 diff
(98.7 %id)
BI260655 cervical carcinoma cell line, cervix .i-u 783 to 1668 1 to 889       889/889
(100 %)
24 diff
(97.4 %id)
AA724679 parathyroid gland, parathyroid tumor .i-u 785 to 1221 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AL578617 placenta .i-u 789 to 1658 871 to 1       871/871
(100 %)
17 diff
(98.1 %id)
BQ720106 sympathetic trunk .i-u 794 to 1527 1 to 739       739/870
(84 %)
13 diff
(98.6 %id)
W73522 heart .i-u 817 to 1222 411 to 1   fully sequenced,   411/411
(100 %)
7 diff
(98.3 %id)
BQ187498 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i-u 845 to 1273 1 to 430   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 430/430
(100 %)
1 diff
(99.8 %id)
BQ185957 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i-u 845 to 1273 1 to 430   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 430/430
(100 %)
2 diff
(99.6 %id)
FN174481 breast carcinoma .i-u 849 to 967 1 to 119       119/119
(100 %)
0 diff
(100 %id)
BF090791 nervous_tumor .i-u 931 to 1125 1 to 201       201/201
(100 %)
14 diff
(93.1 %id)
AA323813 brain, cerebellum .i-u 934 to 1358 1 to 427       427/427
(100 %)
2 diff
(99.6 %id)
BQ227762 epithelioid carcinoma, Pancreas .i-u 955 to 1694 750 to 8 exact   Submitted on the opposite strand 743/942
(78 %)
0 diff
(100 %id)
CA309358 Alveolar Macrophage, lung .i-u 962 to 1704 759 to 17 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 743/743
(100 %)
4 diff
(99.5 %id)
W26813 eye, retina .i-u 975 to 1343 396 to 28       369/414
(89 %)
0 diff
(100 %id)
N35875 melanocyte .i-u 979 to 1363 1 to 385       385/385
(100 %)
1 diff
(99.8 %id)
W27481 eye, retina .i-u 985 to 1274 21 to 311       291/299
(97 %)
0 diff
(100 %id)
CA305883 Alveolar Macrophage, lung .i-u 989 to 1702 731 to 19 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 713/713
(100 %)
1 diff
(99.9 %id)
CA427035 Bone, Subchondral Bone .i-u 1036 to 1702 685 to 19 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 667/667
(100 %)
0 diff
(100 %id)
BE763027 nervous_tumor .i-u 1096 to 1457 362 to 2       361/362
(99 %)
0 diff
(100 %id)
CD678851 eye, Trabecular meshwork .i-u 1104 to 1715 1 to 613 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 613/613
(100 %)
2 diff
(99.7 %id)
W60674 heart .i-u 1126 to 1716 591 to 1 exact     591/591
(100 %)
10 diff
(98.4 %id)
DB384289   .i-u 1132 to 1702 567 to 1 exact     567/567
(100 %)
17 diff
(97.1 %id)
BF434743 Kidney .i-u 1162 to 1702 541 to 1 exact     541/541
(100 %)
0 diff
(100 %id)
BE300888 choriocarcinoma, placenta .i-u 1168 to 1714 554 to 8 exact     547/554
(98 %)
0 diff
(100 %id)
AW368544 head_neck .i-u 1188 to 1383 201 to 1       201/201
(100 %)
0 diff
(100 %id)
TI_154134722   .i-u 1189 to 1702 618 to 100   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 519/1024
(50 %)
29 diff
(97.2 %id)
AI826685 normal prostate, Prostate .i-u 1231 to 1703 474 to 2 exact     473/474
(99 %)
0 diff
(100 %id)
H39518 breast .i-u 1252 to 1675 1 to 430       430/430
(100 %)
7 diff
(98.4 %id)
AI627851 Kidney .i-u 1255 to 1702 448 to 1 N39K F42N I44L     448/448
(100 %)
5 diff
(98.9 %id)
AI139647 uterus .i-u 1263 to 1716 456 to 3 exact tiling clone,   454/456
(99 %)
0 diff
(100 %id)
AW270949 Kidney .i-u 1269 to 1702 434 to 1 F42S I44L     434/434
(100 %)
3 diff
(99.4 %id)
AI573132 adenocarcinoma, Pancreas .i-u 1277 to 1702 426 to 1 exact     426/426
(100 %)
0 diff
(100 %id)
AI924877 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i-u 1278 to 1703 426 to 1 exact     426/426
(100 %)
0 diff
(100 %id)
AI564189 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i-u 1284 to 1699 437 to 22 exact     416/437
(95 %)
0 diff
(100 %id)
AA599931 bone marrow stroma .i-u 1287 to 1716 430 to 1 C46R     430/430
(100 %)
2 diff
(99.6 %id)
BF512967   .i-u 1293 to 1715 440 to 18 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 423/423
(100 %)
0 diff
(100 %id)
BQ334219 marrow .i-u 1310 to 1652 354 to 12       343/354
(96 %)
0 diff
(100 %id)
AA912453 pooled germ cell tumors .i-u 1312 to 1715 430 to 26 C21L K36Q S41T F42I Y43* AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 405/405
(100 %)
12 diff
(97.1 %id)
AI276456 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 1320 to 1704 385 to 1 S41T     385/385
(100 %)
1 diff
(99.8 %id)
N53314 multiple sclerosis lesions .i-u 1329 to 1682 1 to 368       368/370
(99 %)
19 diff
(94.9 %id)
AI075259 B-cell, chronic lymphotic leukemia .i-u 1344 to 1703 368 to 9 exact     360/368
(97 %)
0 diff
(100 %id)
AI969212 lung, two pooled squamous cell carcinomas .i-u 1345 to 1715 388 to 18 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 371/371
(100 %)
2 diff
(99.5 %id)
AA659635 alveolar rhabdomyosarcoma .i-u 1357 to 1613 257 to 1       257/257
(100 %)
0 diff
(100 %id)
BG497340 lung, mucoepidermoid carcinoma .i-u 1387 to 1691 1 to 305 C46G AAA   305/318
(95 %)
2 diff
(99.4 %id)
AI500279 anaplastic oligodendroglioma, brain .i-u 1389 to 1703 319 to 5 exact     315/319
(98 %)
0 diff
(100 %id)
N52065 multiple sclerosis lesions .i-u 1440 to 1716 279 to 2 R9E L10T P11S A12C S13Q ...     278/280
(99 %)
0 diff
(100 %id)
AA494426 colon .i-u 1479 to 1716 242 to 5 exact     238/242
(98 %)
0 diff
(100 %id)
FN107230 breast carcinoma .i-u 1492 to 1579 95 to 4     Submitted on the opposite strand 92/95
(96 %)
0 diff
(100 %id)
FN140077 breast carcinoma .i-u 1582 to 1675 1 to 93       93/93
(100 %)
4 diff
(95.7 %id)
DB097350 testis .j 1 to 592 2 to 593   tiling clone, capped   592/592
(100 %)
1 diff
(99.9 %id)
DA304554 hippocampus .j 393 to 961 2 to 571 G69R S70V L71I P72A D73R ... tiling clone, capped   570/570
(100 %)
3 diff
(99.5 %id)
DB073851 testis .k 1 to 838 2 to 547 exact tiling clone, capped Suspected internal deletion 546/546
(100 %)
13 diff
(97.7 %id)
BX487342   .l-u 1 to 433 1 to 432   tiling clone,   432/432
(100 %)
1 diff
(99.8 %id)
AA610111   .l-u 432 to 687 1 to 255 A26P I27S T28R G29A W30G ... tiling clone, Submitted on the opposite strand 255/255
(100 %)
3 diff
(98.9 %id)
DA633871 Kidney .m 1 to 564 2 to 565 exact tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
DB027631 testis .n 1 to 562 2 to 563 L33P tiling clone, capped   562/562
(100 %)
7 diff
(98.8 %id)
DA317669 hippocampus .o 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DB069238 testis .p 1 to 540 2 to 543 P11L R12P T13R N14T F15L ... tiling clone, capped   542/542
(100 %)
16 diff
(97.1 %id)
N76925 liver and spleen .q-u 1 to 189 189 to 1   tiling clone, Submitted on the opposite strand 189/259
(72 %)
0 diff
(100 %id)
AI015510   .q-u 11 to 371 361 to 1   tiling clone,   361/361
(100 %)
0 diff
(100 %id)
DA054019 cerebellum Gene CRTC3, variant not shown       capped This clone was ignored    
DB299420 cerebellum Gene CRTC3, variant not shown              
DA104970 cerebellum Gene CRTC3, variant not shown       capped      
DA109052 cerebellum Gene CRTC3, variant not shown       capped This clone was ignored    
CV402858 breast_normal Gene CRTC3, variant not shown              
BX472107   Gene CRTC3, variant not shown         Suspected internal deletion, this clone was ignored    
AL709652 human skeletal muscle Gene CRTC3, variant not shown              
DW408815 Liver Gene CRTC3, variant not shown              
BQ637977 eye, retina Gene CRTC3, variant not shown         Suspected internal deletion, this clone was ignored    
BF064019 colon, colon tumor, RER+ Gene CRTC3, variant not shown              
DB061341 testis Gene CRTC3, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB339297 testis Gene CRTC3, variant not shown         Suspected internal deletion, this clone was ignored    
DB073204 testis Gene CRTC3, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB279174 uterus Gene CRTC3, variant not shown       capped This clone was ignored    
DB352370 uterus Gene CRTC3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l-u, .m, .n, .o, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI